U.S.-Japan Cooperative Medical Sciences Program (USJCMSP)
19th International Conference on Emerging Infectious Diseases (EID) in the Pacific Rim
February 7-8, 2017
Venue: Novotel Ambassador Seoul Gangnam - Champagne AB Room, 2nd Floor
130 Bongeunsa ro
Gangnam gu
Seoul, Republic of Korea
The focus of this conference is on antimicrobial resistance (AMR) of bacterial and parasitic diseases of importance in the Asia-Pacific region. The objectives of this conference are to share current research findings and foster existing and potential international research collaborations that engage investigators and institutions in the Asia-Pacific region and the United States.
If you will be using Twitter or Instagram, please use the hashtag #CMSPEID.
Tuesday, 7 February 2017
7:30-8:30                Registration
8:30-9:10                WELCOMING REMARKS
Hideo Suzuki, Chargés d'Affaires ad interim, Embassy of Japan in Seoul
Marc Knapper, Chargé d’Affaires, U.S. Embassy in Seoul
Jerome H. Kim, Director General, International Vaccine Institute (IVI)
Aikichi Iwamoto, Science and Technology Advisor, Japan Agency for Medical Research and Development (AMED) / Japanese Delegation Chair, USJCMSP
Patrick Brennan, University Distinguished Professor, Colorado State University, U.S.A.
/ U.S. Chair Emeritus, USJCMSP


Moderators:         Kenji Hirayama, Nagasaki University, Japan
Jong Seok Lee, International TB Research Center, Korea
Rapporteurs:       Yohei Doi, University of Pittsburgh, U.S.A./Japan
William Petri, University of Virginia School of Medicine, U.S.A.
Introduced by Aikichi Iwamoto, AMED, Japan
9:10-9:40              Masakatsu Shibasaki, Institute of Microbial Chemistry, Japan 9:40-9:50                     Announcement of USJCMSP 2016 Collaborative Awards
9:50-10:00            Break
10:00-10:10          Brief video presentation: IVI Introduction
SESSION 1         Overview of Antimicrobial Resistance Moderators:         Kenji Hirayama, Nagasaki University, Japan
Jong Seok Lee, International TB Research Center, Korea
Rapporteurs:       Yohei Doi, University of Pittsburgh, U.S.A./Japan
William Petri, University of Virginia School of Medicine, U.S.A.
10:10-11:00          Panel Discussion (10 min. talks, followed by discussion) NIH/NIAID and CARB: Combating antibiotic-resistant bacteria
Dennis Dixon, National Institute of Allergy and Infectious Diseases (NIAID), U.S.A.
Overview of AMR in Japan
Kazuhiro Tateda, Toho University, Japan
Overview of AMR in Korea
Seok Hoon Jeong, Yonsei University College of Medicine, Korea
Time for Discussion (20 min.) 11:00-12:00                   Lunch Break and Poster Viewing
SESSION 2         Molecular Epidemiology of Antimicrobial Resistance shorter talks (20 min. each)
Moderators:         Dennis Dixon, NIAID, U.S.A.             Keigo Shibayama, NIID, Japan
Rapporteurs:       Robert Hall, NIAID, U.S.A.                Chie Nakajima, Hokkaido University, Japan
12:00-12:20          The global spread of fluoroquinolone resistant Shigella sonnei
Hao Chung The, Oxford University Clinical Research Unit, Vietnam
12:20-12:40          The reemergence of schistosomiasis in Sichuan, China despite treatment and control: Integrating next-generation genomics and field epidemiology
Elizabeth Carlton, University of Colorado, Denver, U.S.A.
12:40-13:00          Genetic approaches to cryptosporidiosis a leading cause of global child mortality
Boris Striepen, University of Georgia, Athens, U.S.A.
13:00-13:20          Molecular and phenotypic surveys for multidrug-resistant tuberculosis in South East Asia
Yasuhiko Suzuki, Hokkaido University Research Center for Zoonosis Control, Japan
13:20-13:40          NGS technology for molecular typing and DST of M. tuberculosis Jong Seok Lee, International Tuberculosis Research Center, Korea
13:40- 14:00         Global epidemiology of AMR in bacteria
Yohei Doi, University of Pittsburg, Japan and U.S.A.
  14:00-14:20          Discussion
14:20-14:30          Break
SESSION 3         Genomics and Mechanisms of Antimicrobial Resistance shorter talks (20 min. each)
Moderators:         Tim Murphy, State University of New York (SUNY) at Buffalo, U.S.A.
Mitsuaki Nishibuchi, Kyoto University, Japan
Rapporteurs:       Takushi Kaneko, TB Alliance, U.S.A.             Alison Kraigsley, NIAID, U.S.A.
14:30-14:50          Mobile genetic elements in the spread of resistance: overview and current work on the mobile element behind the MRSA epidemic
Phoebe Rice, University of Chicago, U.S.A.
14:50-15:10          Consequences of drug resistant mutations on the whole genome and physiology (fitness)
Yonatan Grad, Harvard School of Public Health, U.S.A.
15:10-15:30          Reactive oxygen species play an important role in the bactericidal activity of quinolone antibiotics
Deepak Nair, Regional Centre for Biotechnology in Faridabad, India
15:30-15:50          Phenotypic variations of L. donovani in Sri Lanka: Threat of antimony resistance?
Nadira Karunaweera, University of Colombo, Sri Lanka
15:50-16:10          New PK/PD strategies to combat resistance
Brian Tsuji, State University of New York at Buffalo, U.S.A.
16:10-16:30          Discussion

Wednesday, 8 February 2017

8:00-8:30                Registration


Moderators:         Kiyoshi Kita, Nagasaki University, Japan
Steve Reed, Infectious Disease Research Institute (IDRI), U.S.A.
Rapporteurs:       Manabu Ato, National Institute of Infectious Diseases (NIID), Japan
James Kazura, Case Western Reserve University, U.S.A.
Introduced by Gray Handley, NIAID, U.S.A.
8:30-9:00                John Mekalanos, Harvard Medical School, U.S.A.
SESSION 4         New Developments in Recognition and Technologies for Prevention, Diagnosis and Treatment of AMR shorter talks (20 min. each)
Moderators:         Kiyoshi Kita, Nagasaki University, Japan        Steve Reed, IDRI, U.S.A.
Rapporteurs:       Manabu Ato, NIID, Japan       James Kazura, Case Western Reserve University, U.S.A
9:00-9:20                Efficacy of topical single radio frequency induced heat therapy (RFHT) in treatment of old world SSG-responsive and SSG-refractory CL caused by L. tropica
Abhay Satoskar, Ohio State University, U.S.A.
9:20-9:40                Colonization and drug resistance in enterotoxigenic E. coli
Michael Lebens, University of Gothenburg, Sweden
9:40-10:00            GeneXpert MTB/RIF and other genetic based tools for surveys of AMR in
Mycobacterium tuberculosis infections
Linda Xie, National Institute of Allergy and Infectious Diseases, U.S.A.
10:00-10:20          Colistin resistance and MCR-1
Yang Wang, China Agricultural University, China
10:20-10:40           How to discover new medicines in resource-limited therapeutic areas?
Takushi Kaneko, TB Alliance, U.S.A.
10:40-11:00          The microbiome as a tool to prevent transmission and infection due to antimicrobial resistant bacterial pathogens
Melinda Mary Pettigrew, Yale University, U.S.A.
11:00 -11:20         Discussion
11:20-11:30          Break

SESSION 5         Malaria Elimination and AMR

Moderators:         Shigeyuki Kano, National Center for Global Health and Medicine, Japan
Malla Rao, NIAID, U.S.A
Rapporteurs:       Shinjiro Hamano, Nagasaki University, Japan
Nadira Karunaweera, University of Colombo, Sri Lanka
11:30-12:00          Mass drug administration to eliminate malaria on islands
Akira Kaneko, NIID, Japan
12:0-12:30            Genomics and drug resistance mechanisms in Plasmodium falciparum population along the China-Myanmar border
Liwang Cui, Penn State University, U.S.A.
12:30-13:30          Lunch Break and Poster Viewing
13:30-14:00          Artemisinin and drug partner resistance: from phenotype to genotype
Didier Menard, Institut Pasteur in Cambodia, Cambodia
14:00-14:30          Molecular epidemiology of Plasmodium vivax malaria in Duffy-negative human in Ethiopia
Guiyun Yan, University of California, Irvine, U.S.A.
SESSION 6         Cancer, Infectious Agents, and Antibiotic Resistance
Moderators:        Tohru Kiyono, National Cancer Center Research Institute, Japan
Ted Trimble, National Cancer Institute, U.S.A.
Rapporteurs:       Marie Ricciardone, National Cancer Institute, U.S.A.
Haruhiko Sugimura, Hamamatsu University School of Medicine, Japan
14:30-15:00          Collaboration between Helicobacter pylori and Epstein-Barr virus in gastric carcinogenesis
Masanori Hatakeyama, University of Tokyo, Japan
15:00-15:10          Break
15:10-15:40          Helicobacter pylori eradication for gastric cancer prevention
Il Ju Choi, National Cancer Center, Korea
15:40-16:10          The human microbiome, gastric cancer prevention, and antimicrobial resistance
Christian Abnet, National Cancer Institute, U.S.A.
16:10-16:40          Contribution of liver fluke and diabetes on development and progression of cholangiocarcinoma
Sopit Wongkham, Khon Kaen University, Thailand
16:40-17:00          Masao Mitsuyama, Kyoto University, Japan
Gray Handley, NIAID, U.S.A.